Header Logo

Connection

Elizabeth Berry-Kravis to Cyclic Nucleotide Phosphodiesterases, Type 4

Back to Details
This is a "connection" page, showing publications Elizabeth Berry-Kravis has written about Cyclic Nucleotide Phosphodiesterases, Type 4.
Elizabeth Berry-Kravis
Connection Strength
0.762
Cyclic Nucleotide Phosphodiesterases, Type 4
  1. Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nat Med. 2021 05; 27(5):862-870.
    View in: PubMed
    Score: 0.762
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.